The Phase 1b/2a clinical trial (NCT04445831), which was sponsored by AC Immune SA (clinical-stage biopharmaceutical company), examined the safety, tolerability, and immunogenicity of two tau-targeted liposomal vaccines, namely ACI-35.030 and JACI-35.054, in the early stages of AD
If levels get too high or side effects occur, we might lower the dosage
The study included 28 patients
Key properties: Highest sustained GH output greater peak amplitude than Ipamorelin Mild cortisol elevation generally considered clinically insignificant at standard doses Moderate appetite increase noticeable but manageable No desensitization unlike Hexarelin, GHRP-2 maintains efficacy with continued use GHRP-2 is the choice when maximizing GH release is the priority and mild side effects are acceptable
However, if you feel like they prevent you from showing off your flawless appearance, dont hesitate to try these techniques